Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-013410
Filing Date
2023-05-19
Accepted
2023-05-19 17:36:48
Documents
2
Period of Report
2023-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10002
2 EX-24 DOCUMENT attachment1.htm EX-24 3774
  Complete submission text file 0000899243-23-013410.txt   15205
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Issuer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATAI LIFE SCIENCES N.V. WALLSTRASSE 16 BERLIN 2M 10179
Business Address
Johnson Anne Nagengast (Reporting) CIK: 0001976640 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40493 | Film No.: 23941700